These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9799763)

  • 1. Simplified interpretative format for assessing test interference: studies with hemoglobin-based oxygen carrier solutions.
    Kazmierczak SC; Catrou PG; Boudreau D
    Clin Chem; 1998 Nov; 44(11):2347-52. PubMed ID: 9799763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple regression analysis of interference effects from a hemoglobin-based oxygen carrier solution.
    Kazmierczak SC; Catrou PG; Best AE; Sullivan SW; Briley KP
    Clin Chem Lab Med; 1999 Apr; 37(4):453-64. PubMed ID: 10369118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for assessing interference.
    Kroll MH; Ruddel M; Blank DW; Elin RJ
    Clin Chem; 1987 Jul; 33(7):1121-3. PubMed ID: 3594838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the interference of hemoglobin, bilirubin, and lipids on Roche Cobas 6000 assays.
    Ji JZ; Meng QH
    Clin Chim Acta; 2011 Aug; 412(17-18):1550-3. PubMed ID: 21575617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-oximetry interference by hemoglobin-based blood substitutes.
    Ali AA; Ali GS; Steinke JM; Shepherd AP
    Anesth Analg; 2001 Apr; 92(4):863-9. PubMed ID: 11273915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and mathematical correction of hemolysis interference in selected Hitachi 717 assays.
    Jay DW; Provasek D
    Clin Chem; 1993 Sep; 39(9):1804-10. PubMed ID: 8375051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of interference of a polymerized hemoglobin blood substitute in an alkaline phosphatase method.
    Chance JJ; Norris EJ; Kroll MH
    Clin Chem; 2000 Sep; 46(9):1331-7. PubMed ID: 10973862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of analytical methods to evaluate SFH.
    Nakai K; Abe H; Matsuda N; Kobayashi M; Ikeda H; Sekiguchi S; Tsuchida E
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):447-51. PubMed ID: 1391462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin interference from in vivo hemolysis.
    Blank DW; Kroll MH; Ruddel ME; Elin RJ
    Clin Chem; 1985 Sep; 31(9):1566-9. PubMed ID: 4028407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for using multiple regression analysis with complex interferences.
    Kroll MH; Chesler R
    Eur J Clin Chem Clin Biochem; 1992 Jul; 30(7):415-24. PubMed ID: 1525264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference with clinical laboratory analyses.
    Kroll MH; Elin RJ
    Clin Chem; 1994 Nov; 40(11 Pt 1):1996-2005. PubMed ID: 7955368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests.
    Ma Z; Monk TG; Goodnough LT; McClellan A; Gawryl M; Clark T; Moreira P; Keipert PE; Scott MG
    Clin Chem; 1997 Sep; 43(9):1732-7. PubMed ID: 9299968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical interference of HBOC-201 (Hemopure, a synthetic hemoglobin-based oxygen carrier) on four common clinical chemistry platforms.
    Korte EA; Pozzi N; Wardrip N; Ayyoubi MT; Jortani SA
    Clin Chim Acta; 2018 Jul; 482():33-39. PubMed ID: 29580857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference in clinical chemistry assays by the hemoglobin-based oxygen carrier, Hemospan.
    Cameron SJ; Gerhardt G; Engelstad M; Young MA; Norris EJ; Sokoll LJ
    Clin Biochem; 2009 Feb; 42(3):221-4. PubMed ID: 19028481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spurious hemoglobin Barts caused by bilirubin: a common interference mimicking an uncommon hemoglobinopathy.
    Howanitz PJ; Kozarski TB; Howanitz JH; Chauhan YS
    Am J Clin Pathol; 2006 Apr; 125(4):608-14. PubMed ID: 16627270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids: a practical approach.
    Vermeer HJ; Steen G; Naus AJ; Goevaerts B; Agricola PT; Schoenmakers CH
    Clin Chem Lab Med; 2007; 45(1):114-9. PubMed ID: 17243928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex analyte-dependent and analyte-independent interferences with conjugated bilirubin in the enzymatic phenol-aminophenazone peroxidase (PAP) method for creatinine determination.
    Eng CD; Delgado R; Kroll MH
    Eur J Clin Chem Clin Biochem; 1993 Dec; 31(12):839-50. PubMed ID: 8136416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylation promotes hemoglobin tetramer dissociation.
    Caccia D; Ronda L; Frassi R; Perrella M; Del Favero E; Bruno S; Pioselli B; Abbruzzetti S; Viappiani C; Mozzarelli A
    Bioconjug Chem; 2009 Jul; 20(7):1356-66. PubMed ID: 19534518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the In Vitro Interference of Hemoglobin, Lipids, and Bilirubin on the Measurement of Plasma Advanced Oxidation Protein Products.
    Cargnin LP; Hausen BS; Tatsch E; Sangoi MB; Moresco RN
    Clin Lab; 2016 Aug; 62(8):1585-1589. PubMed ID: 28164612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A second-derivate fitting algorithm for the quantification of free hemoglobin in human plasma.
    Paal M; Lang A; Hennig G; Buchholtz ML; Sroka R; Vogeser M
    Clin Biochem; 2018 Jun; 56():62-69. PubMed ID: 29655958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.